TRxADE HEALTH, Inc. (NASDAQ:MEDS) Short Interest Update

TRxADE HEALTH, Inc. (NASDAQ:MEDS) was the target of a significant decrease in short interest in the month of June. As of June 15th, there was short interest totalling 6,900 shares, a decrease of 31.0% from the May 31st total of 10,000 shares. Based on an average trading volume of 97,200 shares, the days-to-cover ratio is currently 0.1 days. Currently, 1.4% of the company’s stock are sold short.

TRxADE HEALTH Stock Down 15.1 %

TRxADE HEALTH stock opened at $11.17 on Monday. TRxADE HEALTH has a twelve month low of $3.69 and a twelve month high of $44.56. The stock’s fifty day simple moving average is $6.95 and its 200-day simple moving average is $8.19.

Institutional Trading of TRxADE HEALTH

A hedge fund recently bought a new stake in TRxADE HEALTH stock. Virtu Financial LLC bought a new position in shares of TRxADE HEALTH, Inc. (NASDAQ:MEDS) in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 10,617 shares of the company’s stock, valued at approximately $109,000. Virtu Financial LLC owned approximately 0.75% of TRxADE HEALTH at the end of the most recent quarter. 5.68% of the stock is currently owned by hedge funds and other institutional investors.

TRxADE HEALTH Company Profile

TRxADE HEALTH, Inc operates as a health services information technology (IT) company in the United States. The company focuses on digitalizing the retail pharmacy experience by optimizing drug procurement, prescription journey, and patient engagement; and designs, develops, owns, and operates a business-to-business web-based marketplace.